Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Papa John's (PZZA) upgraded to Buy from Hold at Stifel with analyst Chris O'Cull saying new CEO Rob Lynch's turnaround experience and marketing expertise improves the company's prospects of delivering positive same-restaurant-sales gains over the coming quarters. 2. Targa Resources (TRGP) upgraded to Strong Buy from Outperform at Raymond James with analyst J R Weston saying the recent selloff in the shares is overdone and makes Targa "inexpensive." 3. Livongo Health (LVGO) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Ricky Goldwasser saying after the recent selloff, Livongo shares are trading at a discount to peers. 4. Sea Limited (SE) upgraded to Buy from Outperform at CLSA with analyst Marcus Liu saying the 12% pullback in the shares post the company's Q2 results is overdone. 5. Pfizer (PFE) upgraded to Hold from Sell at DZ Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

Loop Capital upgraded Sea Limited to Buy from Hold with a price target of $92, up from $59. The stock's valuation pressure the last two years is mainly because of aggressive competition and share loss to TikTok, the analyst tells investors in a research note. However, the firm says the recent announcement of a commission rate increase by the combined TikTok-Tokopedia, its first move since merging to satisfy Indonesian regulators, "has sparked a revaluation" Sea shares. Loop believes this signals that the shift to sustained profitable growth is "finally underway" and serves as a significant catalyst for revaluation of Sea Limited. With "competitive rationality" setting in, Loop moved from its "broken stock" valuation framework for Sea.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here

Sea Limited is up 9.0%, or $4.97 to $60.03.

Pfizer announced that the European Commission, or EC, has granted marketing authorization for Emblaveo for the treatment of adult patients with complicated intra-abdominal infections, or cIAI, hospital-acquired pneumonia, or HAP, including ventilator-associated pneumonia, or VAP, and complicated urinary tract infections, or cUTI, including pyelonephritis. It is also indicated for the treatment of infections due to aerobic Gram-negative organisms in adult patients with limited treatment options.

Stifel analyst Chris O'Cull upgraded Papa John's to Hold from Sell with a price target of $60, down from $65. The analyst believes near-term expectations are reasonable. Given the stock's negative sentiment and recent market volatility, the firm decided to move to the sidelines. However, Stifel continues to believe Papa John's is in a "challenging competitive position in a tough category."